Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick H Dashwood

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Antioxidants (Basel, Switzerland)|September 17, 2020
Epigenetic Regulation of NRF2/KEAP1 by PhytochemicalsShamee Bhattacharjee, Roderick H Dashwood
Pharmacological Research|January 22, 2011
Endothelins and their receptors in cancer: identification of therapeutic targetsRong Wang, Roderick H Dashwood
The Journal of Biological Chemistry|August 28, 2004
Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cellsQingjie Li, Roderick H Dashwood
Nutrition Reviews|August 21, 2008
Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanatesRoderick H Dashwood, Emily Ho
Cancer Letters|March 8, 2006
Chemoprotection by sulforaphane: keep one eye beyond Keap1Melinda C Myzak, Roderick H Dashwood
Archives of Biochemistry and Biophysics|April 6, 2010
(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cellsChristine A Larsen, Roderick H Dashwood
Current Drug Targets|April 14, 2006
Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphaneMelinda C Myzak, Roderick H Dashwood
Biochemical and Biophysical Research Communications|September 12, 2009
Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxideChristine A Larsen, Roderick H Dashwood
Cancer Letters|July 28, 2020
Emerging crosstalk between long non-coding RNAs and Nrf2 signalingShamee Bhattacharjee, Jia Li, Roderick H Dashwood
Cancers|March 28, 2024
A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in CancerNivedhitha Mohan, Roderick H Dashwood, Praveen Rajendran
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Antioxidants (Basel, Switzerland)|September 17, 2020
Epigenetic Regulation of NRF2/KEAP1 by PhytochemicalsShamee Bhattacharjee, Roderick H Dashwood
Pharmacological Research|January 22, 2011
Endothelins and their receptors in cancer: identification of therapeutic targetsRong Wang, Roderick H Dashwood
The Journal of Biological Chemistry|August 28, 2004
Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cellsQingjie Li, Roderick H Dashwood
Nutrition Reviews|August 21, 2008
Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanatesRoderick H Dashwood, Emily Ho
Cancer Letters|March 8, 2006
Chemoprotection by sulforaphane: keep one eye beyond Keap1Melinda C Myzak, Roderick H Dashwood
Archives of Biochemistry and Biophysics|April 6, 2010
(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cellsChristine A Larsen, Roderick H Dashwood
Current Drug Targets|April 14, 2006
Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphaneMelinda C Myzak, Roderick H Dashwood
Biochemical and Biophysical Research Communications|September 12, 2009
Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxideChristine A Larsen, Roderick H Dashwood
Cancer Letters|July 28, 2020
Emerging crosstalk between long non-coding RNAs and Nrf2 signalingShamee Bhattacharjee, Jia Li, Roderick H Dashwood
Cancers|March 28, 2024
A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in CancerNivedhitha Mohan, Roderick H Dashwood, Praveen Rajendran
Pageof 14